Reference
1. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of
Tumours of the Digestive System, 4th ed. 2010.
2. Classification of Tumours Editorial Board. WHO Classification of
Tumours of the Digestive System, 5th ed. 2019.
3. Applebaum EL, Mantravadi P, Haas R. Lymphoepithelioma of the
nasopharynx. Laryngoscope 1982; 92: 510-514.
4. Elliot DRF, Gill RM. Undifferentiated variant. In: Gastrointestinal
Pathology, Edited by Gonzalez RS, Volume 13-3, 2019.
5. Iezzoni JC, Gaffey MJ, Weiss LM. The Role of Epstein-Barr Virus in
Lymphoepithelioma-like Carcinomas. Am J Clin Pathol 1995; 103:
308-315.
6. Labgaa I, Stueck A, Ward SC. Lymphoepithelioma-Like Carcinoma in
Liver. Am J Pathol 2017; 187: 1438-1444.
7. Putra J, Anderson TA, Roayaie S, Maeda M, Thung SN. Metastatic
lymphoepithelioma-like hepatocellular carcinoma: A potential diagnostic
pitfall and demonstration of Pd-l1 expression. Annals of
Hepatology 2017; 16: 157-159.
8. Shirabe K, Matsumata T, Maeda T, Sadanaga N, Kuwano H, Sugimachi K. A
long-term surviving patient with hepatocellular carcinoma including
lymphocytes infiltration - A clinicopathological study.Hepatogastroenterology 1995; 42: 996-1001.
9. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M.
Clinicopathological study on hepatocellular carcinoma with lymphocytic
infiltration. Hepatology 1998; 27: 407-414.
10. Emile JF, Adam R, Sebagh M, et al. Hepatocellular carcinoma with
lymphoid stroma: A tumour with good prognosis after liver
transplantation. Histopathology 2000; 37: 523-529.
11. Si MW, Thorson JA, Lauwers GY, DalCin P, Furman J. Hepatocellular
lymphoepithelioma-like carcinoma associated with Epstein Barr virus: A
Hitherto unrecognized entity. Diagn Mol Pathol 2004; 13: 183-189.
12. Chen CJ, Jeng L Bin, Huang SF. Lymphoepithelioma-like hepatocellular
carcinoma. Chang Gung Med J 2007; 30: 172-177.
13. Nemolato S, Fanni D, Naccarato AG, Ravarino A, Bevilacqua G, Faa G.
Lymphoepitelioma-like hepatocellular carcinoma: A case report and a
review of the literature. World J Gastroenterol 2008; 14:
4694-4696.
14. Park HS, Jang KY, Kim YK, Cho BH, Moon WS. Hepatocellular carcinoma
with massive lymphoid infiltration: A regressing phenomenon?Pathol Res Pract 2009; 205: 648-652.
15. Shinoda M, Kadota Y, Tsujikawa H, et al. Lymphoepithelioma-like
hepatocellular carcinoma: A case report and a review of the literature.World J Surg Oncol 2013; 11: 97.
16. Patel KR, Liu TC, Vaccharajani N, Chapman WC, Brunt EM.
Characterization of inflammatory (lymphoepithelioma-like) hepatocellular
carcinoma: A study of 8 cases. Arch Pathol Lab Med 2014; 138:
1193-1202.
17. An SL, Liu LG, Zheng YL, et al. Primary lymphoepithelioma-like
hepatocellular carcinoma: Report of a locally advanced case and review
of literature. Int J Clin Exp Pathol 2015; 8: 3282-3287.
18. Chan AWH, Tong JHM, Pan Y, et al. Lymphoepithelioma-like
hepatocellular carcinoma: An uncommon variant of hepatocellular
carcinoma with favorable outcome. Am J Surg Pathol 2015; 39:
304-312.
19. Insilla AC, Faviana P, Pollina LE, et al. Lymphoepithelioma-like
hepatocellular carcinoma: Case report and review of the literature.World J Gastroenterol 2015; 21: 10468-10474.
20. Wei J, Liu Q, Wang C, Yu S. Lymphoepithelioma-like hepatocellular
carcinoma without Epstein-Barr virus infection: A case report and a
review of the literature. Indian J Pathol Microbiol 2015; 58:
550-553.
21. Miyasaka C, Ishida M, Ito H, Kaibori M, Uemura Y, Tsuta K.
Lymphoepithelioma-like hepatocellular carcinoma: A case report with
emphasis on the cytological features. Int J Clin Exp Pathol 2017;
10: 7893-7897.
22. Wang JK, Jin YW, Hu HJ, et al. Lymphoepithelioma-like hepatocellular
carcinoma. A case report and brief review of literature. Medicine2017; 96: e9416.
23. Shih EJ, Chau IY, Yeh YC, Chau GY. Synchronous hepatocellular
carcinoma and lymphoepithelioma-like carcinoma arising from 2 different
sites of the liver: A case report. Medicine 2018; 97: e12548.
24. Filotico M, Moretti V, Floccari F, D’Amuri A. Very Rare Liver
Neoplasm: Lymphoepithelioma-Like (LEL) Hepatocellular Carcinoma .Case Rep Pathol 2018; 2018: 2651716.
25. Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus Bevacizumab in
Unresectable Hepatocellular Carcinoma. N Engl J Med 2020; 382:
1894-1905.
26. Chan AWH, Zhang Z, Chong CCN, Tin EKY, Chow C, Wong N. Genomic
landscape of lymphoepithelioma-like hepatocellular carcinoma. J
Pathol 2019; 249: 166-172.
27. Kim C, Rajan A, DeBrito PA, Giaccone G. Metastatic
lymphoepithelioma-like carcinoma of the lung treated with nivolumab: A
case report and focused review of literature. Translational Lung
Cancer Research 2016; 5: 720-726.
28. Kumar V, Dave V, Harris J, Huang Y. Response of advanced stage
recurrent lymphoepithelioma-like carcinoma to nivolumab.Immunotherapy 2017; 9: 955-961.
29. Calderaro J, Rousseau B, Amaddeo G, et al. Programmed death ligand 1
expression in hepatocellular carcinoma: Relationship with clinical and
pathological features. Hepatology 2016; 64: 2038-2046.
30. Hartley GP, Chow L, Ammons DT, Wheat WH, Dow SW. Programmed cell
death ligand 1 (PD-L1) signaling regulates macrophage proliferation and
activation. Cancer Immunology Research 2018; 6: 1260-1273.